21 assets in T-Cell Adult Acute Lymphocytic Leukemia

Therapeutic assets addressing T-Cell Adult Acute Lymphocytic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Adriamycin T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (68)
Etoposide T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (68)
Prednisone T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (68)
Cyclophosphamide T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (67)
Cytarabine T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (66)
Vincristine Sulfate T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (66)
Dexasone T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (65)
(+)-Vincristine T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (65)
Methotrexate T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (62)
Bortezomib T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Daunomycin T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Hydrocortisone T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Isocyclophosphamide T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Mercaptopurine Anhydrous T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Pegaspargase T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Thioguanine Anhydrous T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	B (60)
Dasatinib T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P2	B (57)
Nivestim T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P2	CCC (53)
Sirolimus T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P2	CCC (53)
Tacrolimus T-Cell Adult Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P2	CCC (53)
trx103 T-Cell Adult Acute Lymphocytic Leukemia	Tr1X, Inc.	P1	NR ()